Increased serum leptin expression has been reported in breast cancer and pancreatic cancer [8,14,15], whereas lower serum leptin levels have been observed in gastrointestinal cancers like gastric cancer and colon cancer [7,9]. This evidence concerns the gene LEP and malignant colon neoplasm.